First and only pen device with half-unit dosing increments….
Read More »Cyrus Desouza, MBBS, Q1: Cardiovascular Benefits of SGLT2s, GLP-1s, and DPP-4s?
Dr. Cyrus Desouza, MBBS, talks about the cardiovascular side effects of newer classes of drugs. SGLT2 inhibitors are still relatively new so there is not much information but they do show some weight loss effects, seem to lower blood pressure, and may have some CV benefits. However, we don’t know what they …
Read More »Glucotoxicity Activates the Growth and Spread of Cancer
Sugar intake seems to promote the growth and spread of tumors in fruit flies through a few pathways….
Read More »Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes
This study systemically reviewed randomized controlled trials and observational studies to evaluate whether actual exposure of metformin can be associated with cancer and cancer mortality in type 2 diabetes patients….
Read More »Diabetes and Cardiovascular Risk in Metabolically Healthy Obese Individuals
Do metabolically healthy obese individuals have higher risks for diabetes and CVD?…
Read More »Metformin Boosts Survival in Men with Diabetes, Prostate Cancer
The longer patients were treated with metformin after being diagnosed with prostate cancer, the greater their survival rates were, depending on the dose they were given….
Read More »Sugar-Sweetened Beverages and Weight Gain in 2- to 5-Year-Old Children
Sugar-sweetened beverages cause weight gain for four and five year-old children and put two year olds at greater risk for future weight gain….
Read More »Diabetic Emergencies: Diabetic Ketoacidosis in Childhood and Adolescence, Part 3 of 3
Christina Kanaka-Gantenbein, MD, PhD Acidosis management Severe acidosis is reversible by fluid and insulin replacement. Insulin stops lipolysis and further ketone production and allows ketoacids to be metabolized, generating bicarbonate.4 Moreover, treatment of hypovolemia improves tissue perfusion and renal function, thereby increasing the excretion of organic acids. Controlled trials have …
Read More »Diabetes ‘Cure’ Explained after Gastric Bypass
‘Reprogrammed’ glucose uptake in the small intestine may explain why gastric bypass surgery can sometimes result in the early resolution of type 2 diabetes….
Read More »No Cancer Linked to GLP-1 Compounds
According to the European Medicines Agency’s Committee for Medicinal Products for Human Use, current data linking glucagon-like-peptide-1 (GLP-1) agonists to adverse pancreatic events are not adequate….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.